Results 161 to 170 of about 22,145 (200)

Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell

Cellular Immunology, 2012
In this study, we investigate the relationship between natural killer (NK) cell susceptibility and the surface markers of cancer cells. Through phenotypic analysis, we found evidence that more susceptible cancer cell lines (K562 and Jurkat) express more NKG2D ligands.
Deok Sung, Bae, Yu Kyeong, Hwang, Jae Kwon, Lee   +2 more
openaire   +2 more sources

Targeting NKG2D in tumor surveillance

Expert Opinion on Therapeutic Targets, 2012
NKG2D (natural killer group 2, member D) is expressed on the surface of all mouse and human NK cells, and subpopulation of T cells. Stimulation of NK cells through NKG2D triggers cell-mediated cytotoxicity and induces the production of cytokines. NKG2D binds to family of unique ligands with structurally similar to MHC class I, however, NKG2D ligands ...
openaire   +2 more sources

NKG2D Activating Receptor

2012
Information on receptor ligand systems used by NK cells to specifically detect transformed cells has been accumulating rapidly. Killer cell lectin-like receptor subfamily K, member 1, also known as KLRK1, is the product of human gene. The KLRK1 has been designated as CD314 and contains a C-type lectin-like domain (CTLD).
Rajesh K. Gupta, G. S. Gupta
openaire   +1 more source

NKG2D in Innate and Adaptive Immunity

2005
The term “NK receptors” has been applied to a growing number of cell surface receptors that were initially identified by their expression on NK cells. However, it is becoming increasingly obvious that few or none of the known “NK receptors” are completely restricted in expression to NK cells.
openaire   +2 more sources

NKG2D

2012
Michael T. McCarthy, Christopher A. O’Callaghan   +1 more
openaire   +1 more source

Dual role of NKG2D of NKG2D in NK cell physiology

2009
Predavanje se je odnosilo na ulogu NKG2D receptora u razvoju NK stanica, a na osnovu rezultata dobivenih analizom NKG2D-deficitnih ...
openaire  

NKG2D

2018
Michael T. McCarthy, Christopher A. O’Callaghan   +1 more
openaire   +1 more source

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications

Cells, 2021
Katarzyna Bogunia-Kubik, Jagoda Siemaszko   +1 more
exaly  

NKG2D

2016
Michael T. McCarthy, Christopher A. O’Callaghan   +1 more
openaire   +1 more source

People also looked at

Frontiers in Immunology, 2018
Vedrana Jelenčić, Felix M Wensveen, Bojan Polić   +2 more
exaly   +2 more sources